Chun Cao Selected Research

3-methylhistidine

1/2017	Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats.
1/2017	Mild hypothermia ameliorates muscle wasting in septic rats associated with hypothalamic AMPK-induced autophagy and neuropeptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun Cao Research Topics

Disease

4	Sepsis (Septicemia) 02/2022 - 01/2017
4	Neoplasms (Cancer) 11/2020 - 10/2010
2	Atrophy 02/2022 - 01/2020
2	Insulin Resistance 02/2022 - 01/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2017 - 01/2017
1	Body Weight (Weight, Body) 02/2022
1	Male Infertility (Male Sterility) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Glaucoma 12/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019
1	Frailty 01/2018
1	Critical Illness (Critically Ill) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Hypothermia 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Mesenteric Ischemia 03/2016
1	Chronic Renal Insufficiency 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Philadelphia Chromosome 01/2015
1	Disease Progression 12/2014
1	Plasmablastic Lymphoma 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2010
1	Colonic Neoplasms (Colon Cancer) 10/2010
1	Breast Neoplasms (Breast Cancer) 10/2010
1	Yellow Fever 11/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2010
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018 - 01/2017
2	Muscle Proteins (Muscle Protein)IBA 02/2022 - 01/2020
2	SulfonamidesIBA 12/2021 - 11/2020
2	NeuropeptidesIBA 01/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2017
2	3-methylhistidineIBA 01/2017 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 01/2017
1	LeptinIBA 02/2022
1	CorticosteroneIBA 02/2022
1	octanoic acid (caprylic acid)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	LipidsIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 12/2021
1	carzenideIBA 12/2021
1	Antifungal AgentsIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	artemisinin (artemisinine)IBA 11/2020
1	CytokinesIBA 05/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	UbiquitinIBA 01/2017
1	Ligases (Synthetase)IBA 01/2017
1	Dexmedetomidine FDA Link 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2016
1	Histone Deacetylase 1IBA 11/2016
1	Histones (Histone)IBA 11/2016
1	Complement C5a (Complement 5a)IBA 03/2016
1	Organic Cation Transporter 1IBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	Immunoglobulin M (IgM)IBA 12/2014
1	RNA (Ribonucleic Acid)IBA 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014
1	Thalidomide (Thalomid)FDA Link 10/2014
1	Bortezomib (Velcade)FDA Link 10/2014
1	Prednisone (Sone)FDA LinkGeneric 10/2014
1	Vincristine (Oncovin)FDA LinkGeneric 10/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2014
1	SphingomyelinsIBA 10/2010
1	SuspensionsIBA 10/2010
1	Cadherins (E-Cadherin)IBA 10/2010
1	sphingosine kinaseIBA 10/2010
1	EnzymesIBA 10/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010
1	SphingolipidsIBA 10/2010
1	Insulin-Like PeptidesIBA 11/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 05/2019 - 10/2014
2	Therapeutics 01/2019 - 01/2015
1	Enteral Nutrition (Feeding, Tube) 02/2022
1	Critical Care (Surgical Intensive Care) 01/2018
1	Anesthesia 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2017
1	Deep Hypothermia Induced Circulatory Arrest 01/2016